Walter Kowtoniuk BS, PhD

Walt was integral in the creation and building of Fulcrum Therapeutics, joining the company full time to lead strategy, business development, and operations. As part of the leadership team, he was involved in advancing the pipeline to its first clinical candidate and growing the company to 40+ employees.
Walt has also worked in strategy consulting with Clarion Healthcare developing new business strategies and providing commercial insight into early product development in the rare disease space. He has a Ph.D. in chemical biology from Harvard University and a B.S. in biochemistry, molecular biology, and philosophy from Gettysburg College. Walt is also a member of Corporate Advisory Council for National Tay-Sachs and Allied Diseases (NTSAD).